142 related articles for article (PubMed ID: 34817517)
1. Gamma-glutamyl transpeptidase-platelet ratio, systemic immune inflammation index, and system inflammation response index in invasive Aspergillosis.
Çakır N; Koc AN
Rev Assoc Med Bras (1992); 2021 Jul; 67(7):1021-1025. PubMed ID: 34817517
[TBL] [Abstract][Full Text] [Related]
2. Value of GPR, APPRI and FIB-4 in the early diagnosis of hepatocellular carcinoma: a prospective cohort study.
Zhang L; Li S; Zhang D; Yin C; Wang Z; Chen R; Cheng N; Bai Y
Jpn J Clin Oncol; 2024 Feb; 54(2):129-136. PubMed ID: 37869774
[TBL] [Abstract][Full Text] [Related]
3. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
4. Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B.
Liu D; Li J; Lu W; Wang Y; Zhou X; Huang D; Li X; Ding R; Zhang Z
Clin Microbiol Infect; 2019 Apr; 25(4):514.e1-514.e8. PubMed ID: 29906588
[TBL] [Abstract][Full Text] [Related]
5. Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?
Desalegn H; Aberra H; Berhe N; Gundersen SG; Johannessen A
Liver Int; 2017 Oct; 37(10):1461-1467. PubMed ID: 28222249
[TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
[TBL] [Abstract][Full Text] [Related]
7. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection.
Ke MY; Zhang M; Su Q; Wei S; Zhang J; Wang Y; Wu R; Lv Y
J Surg Res; 2018 Nov; 231():403-410. PubMed ID: 30278960
[TBL] [Abstract][Full Text] [Related]
8. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.
Wu X; Cai B; Su Z; Li Y; Xu J; Deng R; Wang L
J Clin Lab Anal; 2018 May; 32(4):e22341. PubMed ID: 29251384
[TBL] [Abstract][Full Text] [Related]
9. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
10. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
11. Gamma-glutamyl transpeptidase to platelet and gamma-glutamyl transpeptidase to lymphocyte ratio in a sample of Chinese Han population.
Chen W; Hong D; Chen Z; Dai X; Cao J; Yu M; Li L
BMC Gastroenterol; 2022 Oct; 22(1):442. PubMed ID: 36316645
[TBL] [Abstract][Full Text] [Related]
12. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
13. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):913-922. PubMed ID: 32147439
[TBL] [Abstract][Full Text] [Related]
14. The age, bilirubin and albumin (ABA) index: a novel noninvasive index for predicting liver fibrosis in patients with chronic hepatitis C infection.
Yilmaz B; Kayadibi H; Yeniova AO; Koseoglu H; Simsek Z
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e290-e296. PubMed ID: 33405426
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
[TBL] [Abstract][Full Text] [Related]
16. A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis B.
Wang J; Xia J; Zhang R; Yan X; Yang Y; Zhao X; Chang H; Wang G; Chen G; Liu Y; Chen Y; Jia B; Zhang Z; Ding W; Huang R; Wu C
J Viral Hepat; 2018 Oct; 25(10):1151-1160. PubMed ID: 29741221
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy.
Kim MN; Lee JH; Chon YE; Ha Y; Hwang SG
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):433-439. PubMed ID: 31490417
[TBL] [Abstract][Full Text] [Related]
18. The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients.
Li Q; Lu C; Li W; Huang Y; Chen L
J Viral Hepat; 2017 Dec; 24(12):1143-1150. PubMed ID: 28685907
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of inflammatory parameters in patients with hepatic hydatid disease.
Fan Z; Hu Y; Wang L; Jiang H; Li D; Zhao H; Wang Z
Ann Med; 2021 Dec; 53(1):1370-1376. PubMed ID: 34405745
[TBL] [Abstract][Full Text] [Related]
20. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales.
Michalak A; Cichoż-Lach H; Guz M; Kozicka J; Cybulski M; Jeleniewicz W; Stepulak A
World J Gastroenterol; 2020 Dec; 26(47):7538-7549. PubMed ID: 33384553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
